Global IVD ELISA Reagents Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global IVD ELISA Reagents market size was valued at US$ 1694 million in 2025 and is forecast to a readjusted size of US$ 2321 million by 2032 with a CAGR of 4.6% during review period.
IVD ELISA Reagents refer to complete in vitro diagnostic reagent systems based on enzyme-linked immunosorbent assay technology for detecting pathogen antigens or antibodies, autoantibodies, hormones, tumor-related markers, and specialty protein biomarkers in human serum, plasma, and other clinical specimens. A typical product generally includes pre-coated microplates, enzyme-labeled antibodies or antigens, calibrators, controls, sample diluents, wash buffers, chromogenic substrates, stop solutions, and related auxiliary components. These reagents are widely used in infectious disease screening, blood safety testing, autoimmune disease diagnostics, endocrine and reproductive testing, and selected specialty biomarker assays. Key upstream materials include recombinant antigens, monoclonal and polyclonal antibodies, horseradish peroxidase or alkaline phosphatase conjugates, polystyrene microplates, bovine serum albumin, buffering salts, chromogenic substrates, stabilizers, preservatives, and medical-grade packaging materials. Major downstream customers include hospital clinical laboratories, blood centers and blood screening institutions, independent medical laboratories, public health and disease control agencies, and diagnostic reagent distribution channels. The overall gross margin of the global IVD ELISA reagent industry in 2025 is estimated at approximately 48%–59%.
The global market for IVD ELISA reagents has entered a mature stage, with demand supported by infectious disease serology, blood safety screening, autoimmune disease testing, endocrine diagnostics, and selected specialty biomarker applications. Although ELISA products continue to face pressure from chemiluminescence immunoassays, molecular diagnostics, and more automated testing platforms, they still retain practical value in batch-based workflows, established laboratory routines, broad assay menu coverage, and cost-sensitive testing environments. They remain particularly relevant in blood centers, public health laboratories, regional diagnostic facilities, and markets where testing systems are expected to balance reliability with operating efficiency. The competitive structure is becoming increasingly segmented, as routine screening assays are more exposed to scale and price competition, while specialty assays rely more heavily on clinical differentiation, stability, and brand credibility.
Looking ahead, the industry is likely to evolve through a combination of pressure on conventional assays, stronger emphasis on specialty applications, and continued optimization of product portfolios. Routine infectious disease screening products will remain under competitive pressure as large laboratories in mature markets continue to adopt more automated platforms. At the same time, ELISA reagents still offer room for expansion in autoimmune diagnostics, disease monitoring, specialty proteins, and selected applications involving alternative specimen types. Recent official industry activity, including asset acquisitions and new assay launches, indicates that the segment is not simply declining, but is instead shifting toward higher-value and more clinically differentiated applications. Future competition will increasingly depend on assay quality, regulatory readiness, specimen compatibility, and the depth of clinical utility rather than on the simple expansion of conventional menus.
The main growth drivers remain persistent needs in infectious disease surveillance, blood safety, autoimmune disease recognition, and specialty diagnostics. In addition, high-quality ELISA reagents continue to play a useful role in public health programs, disease management, and differentiated clinical testing strategies. The ongoing evolution of European IVD regulation is also reshaping the market by requiring stronger quality systems, more rigorous performance evaluation, and more comprehensive lifecycle management. While these requirements raise compliance costs, they also help reduce low-quality fragmented supply and favor manufacturers with durable product registration capabilities and stronger international operating discipline. Meanwhile, several companies continue to strengthen their specialty diagnostic portfolios, suggesting that regulatory pressure and clinical demand are jointly driving market upgrading rather than simple market contraction.
The key constraints are also clear. Highly standardized screening assays are more vulnerable to procurement pressure, pricing competition, and technological substitution, which limits both profitability and long-term growth potential. Smaller suppliers without differentiated assays, sufficient regulatory resources, or robust quality management systems may find it increasingly difficult to defend their positions. In addition, ELISA reagent development requires careful control of antigen and antibody selection, conjugation processes, reagent stability, and lot-to-lot consistency. Manufacturers that want to operate across regions must also navigate different regulatory expectations and laboratory usage habits, which increases the burden of validation, registration, and after-sales support. Overall, the market is expected to remain stable, but future competitive advantage will increasingly depend on specialty assay depth, regulatory strength, scenario adaptability, and resilient supply capabilities.
This report is a detailed and comprehensive analysis for global IVD ELISA Reagents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IVD ELISA Reagents market size and forecasts, in consumption value ($ Million), 2021-2032
Global IVD ELISA Reagents market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global IVD ELISA Reagents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global IVD ELISA Reagents market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
IVD ELISA Reagents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IVD ELISA Reagents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD ELISA Reagents, with revenue, gross margin, and global market share of IVD ELISA Reagents from 2021 to 2026.
Chapter 3, the IVD ELISA Reagents competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and IVD ELISA Reagents market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD ELISA Reagents.
Chapter 13, to describe IVD ELISA Reagents research findings and conclusion.
IVD ELISA Reagents refer to complete in vitro diagnostic reagent systems based on enzyme-linked immunosorbent assay technology for detecting pathogen antigens or antibodies, autoantibodies, hormones, tumor-related markers, and specialty protein biomarkers in human serum, plasma, and other clinical specimens. A typical product generally includes pre-coated microplates, enzyme-labeled antibodies or antigens, calibrators, controls, sample diluents, wash buffers, chromogenic substrates, stop solutions, and related auxiliary components. These reagents are widely used in infectious disease screening, blood safety testing, autoimmune disease diagnostics, endocrine and reproductive testing, and selected specialty biomarker assays. Key upstream materials include recombinant antigens, monoclonal and polyclonal antibodies, horseradish peroxidase or alkaline phosphatase conjugates, polystyrene microplates, bovine serum albumin, buffering salts, chromogenic substrates, stabilizers, preservatives, and medical-grade packaging materials. Major downstream customers include hospital clinical laboratories, blood centers and blood screening institutions, independent medical laboratories, public health and disease control agencies, and diagnostic reagent distribution channels. The overall gross margin of the global IVD ELISA reagent industry in 2025 is estimated at approximately 48%–59%.
The global market for IVD ELISA reagents has entered a mature stage, with demand supported by infectious disease serology, blood safety screening, autoimmune disease testing, endocrine diagnostics, and selected specialty biomarker applications. Although ELISA products continue to face pressure from chemiluminescence immunoassays, molecular diagnostics, and more automated testing platforms, they still retain practical value in batch-based workflows, established laboratory routines, broad assay menu coverage, and cost-sensitive testing environments. They remain particularly relevant in blood centers, public health laboratories, regional diagnostic facilities, and markets where testing systems are expected to balance reliability with operating efficiency. The competitive structure is becoming increasingly segmented, as routine screening assays are more exposed to scale and price competition, while specialty assays rely more heavily on clinical differentiation, stability, and brand credibility.
Looking ahead, the industry is likely to evolve through a combination of pressure on conventional assays, stronger emphasis on specialty applications, and continued optimization of product portfolios. Routine infectious disease screening products will remain under competitive pressure as large laboratories in mature markets continue to adopt more automated platforms. At the same time, ELISA reagents still offer room for expansion in autoimmune diagnostics, disease monitoring, specialty proteins, and selected applications involving alternative specimen types. Recent official industry activity, including asset acquisitions and new assay launches, indicates that the segment is not simply declining, but is instead shifting toward higher-value and more clinically differentiated applications. Future competition will increasingly depend on assay quality, regulatory readiness, specimen compatibility, and the depth of clinical utility rather than on the simple expansion of conventional menus.
The main growth drivers remain persistent needs in infectious disease surveillance, blood safety, autoimmune disease recognition, and specialty diagnostics. In addition, high-quality ELISA reagents continue to play a useful role in public health programs, disease management, and differentiated clinical testing strategies. The ongoing evolution of European IVD regulation is also reshaping the market by requiring stronger quality systems, more rigorous performance evaluation, and more comprehensive lifecycle management. While these requirements raise compliance costs, they also help reduce low-quality fragmented supply and favor manufacturers with durable product registration capabilities and stronger international operating discipline. Meanwhile, several companies continue to strengthen their specialty diagnostic portfolios, suggesting that regulatory pressure and clinical demand are jointly driving market upgrading rather than simple market contraction.
The key constraints are also clear. Highly standardized screening assays are more vulnerable to procurement pressure, pricing competition, and technological substitution, which limits both profitability and long-term growth potential. Smaller suppliers without differentiated assays, sufficient regulatory resources, or robust quality management systems may find it increasingly difficult to defend their positions. In addition, ELISA reagent development requires careful control of antigen and antibody selection, conjugation processes, reagent stability, and lot-to-lot consistency. Manufacturers that want to operate across regions must also navigate different regulatory expectations and laboratory usage habits, which increases the burden of validation, registration, and after-sales support. Overall, the market is expected to remain stable, but future competitive advantage will increasingly depend on specialty assay depth, regulatory strength, scenario adaptability, and resilient supply capabilities.
This report is a detailed and comprehensive analysis for global IVD ELISA Reagents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IVD ELISA Reagents market size and forecasts, in consumption value ($ Million), 2021-2032
Global IVD ELISA Reagents market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global IVD ELISA Reagents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global IVD ELISA Reagents market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for IVD ELISA Reagents
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
IVD ELISA Reagents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Antigen Detection
- Antibody Detection
- Hormone Detection
- Other
- Qualitative Assays
- Semi-quantitative Assays
- Quantitative Assays
- Sandwich ELISA
- Indirect ELISA
- Other
- Hospitals and Clinical Laboratories
- Blood Centers and Plasma Screening Institutions
- Independent Medical Laboratories
- Other
- Bio-Rad Laboratories
- Revvity
- Sebia
- Tecan Group
- BioVendor Group
- Trinity Biotech
- Dia.Pro Diagnostic Bioprobes
- Vircell
- SERION Diagnostics
- DRG International
- Demeditec Diagnostics
- Mediagnost
- AESKU.GROUP
- Monobind
- Diagnostics Biochem Canada
- Epitope Diagnostics
- Beijing Wantai Biological Pharmacy Enterprise
- Shanghai Kehua Bio-engineering
- Livzon Pharmaceutical Group
- Daan Gene
- InTec PRODUCTS
- J. Mitra & Co.
- Meril Life Sciences
- Tulip Diagnostics
- Medical & Biological Laboratories
- GenBody
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IVD ELISA Reagents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD ELISA Reagents, with revenue, gross margin, and global market share of IVD ELISA Reagents from 2021 to 2026.
Chapter 3, the IVD ELISA Reagents competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and IVD ELISA Reagents market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD ELISA Reagents.
Chapter 13, to describe IVD ELISA Reagents research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVD ELISA Reagents by Type
1.3.1 Overview: Global IVD ELISA Reagents Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global IVD ELISA Reagents Consumption Value Market Share by Type in 2025
1.3.3 Antigen Detection
1.3.4 Antibody Detection
1.3.5 Hormone Detection
1.3.6 Other
1.4 Classification of IVD ELISA Reagents by Assay Output
1.4.1 Overview: Global IVD ELISA Reagents Market Size by Assay Output: 2021 Versus 2025 Versus 2032
1.4.2 Global IVD ELISA Reagents Consumption Value Market Share by Assay Output in 2025
1.4.3 Qualitative Assays
1.4.4 Semi-quantitative Assays
1.4.5 Quantitative Assays
1.5 Classification of IVD ELISA Reagents by Assay Format
1.5.1 Overview: Global IVD ELISA Reagents Market Size by Assay Format: 2021 Versus 2025 Versus 2032
1.5.2 Global IVD ELISA Reagents Consumption Value Market Share by Assay Format in 2025
1.5.3 Sandwich ELISA
1.5.4 Indirect ELISA
1.5.5 Other
1.6 Global IVD ELISA Reagents Market by Application
1.6.1 Overview: Global IVD ELISA Reagents Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals and Clinical Laboratories
1.6.3 Blood Centers and Plasma Screening Institutions
1.6.4 Independent Medical Laboratories
1.6.5 Other
1.7 Global IVD ELISA Reagents Market Size & Forecast
1.8 Global IVD ELISA Reagents Market Size and Forecast by Region
1.8.1 Global IVD ELISA Reagents Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global IVD ELISA Reagents Market Size by Region, (2021-2032)
1.8.3 North America IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.4 Europe IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.6 South America IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa IVD ELISA Reagents Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Bio-Rad Laboratories
2.1.1 Bio-Rad Laboratories Details
2.1.2 Bio-Rad Laboratories Major Business
2.1.3 Bio-Rad Laboratories IVD ELISA Reagents Product and Solutions
2.1.4 Bio-Rad Laboratories IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.2 Revvity
2.2.1 Revvity Details
2.2.2 Revvity Major Business
2.2.3 Revvity IVD ELISA Reagents Product and Solutions
2.2.4 Revvity IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Revvity Recent Developments and Future Plans
2.3 Sebia
2.3.1 Sebia Details
2.3.2 Sebia Major Business
2.3.3 Sebia IVD ELISA Reagents Product and Solutions
2.3.4 Sebia IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sebia Recent Developments and Future Plans
2.4 Tecan Group
2.4.1 Tecan Group Details
2.4.2 Tecan Group Major Business
2.4.3 Tecan Group IVD ELISA Reagents Product and Solutions
2.4.4 Tecan Group IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Tecan Group Recent Developments and Future Plans
2.5 BioVendor Group
2.5.1 BioVendor Group Details
2.5.2 BioVendor Group Major Business
2.5.3 BioVendor Group IVD ELISA Reagents Product and Solutions
2.5.4 BioVendor Group IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 BioVendor Group Recent Developments and Future Plans
2.6 Trinity Biotech
2.6.1 Trinity Biotech Details
2.6.2 Trinity Biotech Major Business
2.6.3 Trinity Biotech IVD ELISA Reagents Product and Solutions
2.6.4 Trinity Biotech IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Trinity Biotech Recent Developments and Future Plans
2.7 Dia.Pro Diagnostic Bioprobes
2.7.1 Dia.Pro Diagnostic Bioprobes Details
2.7.2 Dia.Pro Diagnostic Bioprobes Major Business
2.7.3 Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Product and Solutions
2.7.4 Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Dia.Pro Diagnostic Bioprobes Recent Developments and Future Plans
2.8 Vircell
2.8.1 Vircell Details
2.8.2 Vircell Major Business
2.8.3 Vircell IVD ELISA Reagents Product and Solutions
2.8.4 Vircell IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Vircell Recent Developments and Future Plans
2.9 SERION Diagnostics
2.9.1 SERION Diagnostics Details
2.9.2 SERION Diagnostics Major Business
2.9.3 SERION Diagnostics IVD ELISA Reagents Product and Solutions
2.9.4 SERION Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 SERION Diagnostics Recent Developments and Future Plans
2.10 DRG International
2.10.1 DRG International Details
2.10.2 DRG International Major Business
2.10.3 DRG International IVD ELISA Reagents Product and Solutions
2.10.4 DRG International IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 DRG International Recent Developments and Future Plans
2.11 Demeditec Diagnostics
2.11.1 Demeditec Diagnostics Details
2.11.2 Demeditec Diagnostics Major Business
2.11.3 Demeditec Diagnostics IVD ELISA Reagents Product and Solutions
2.11.4 Demeditec Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Demeditec Diagnostics Recent Developments and Future Plans
2.12 Mediagnost
2.12.1 Mediagnost Details
2.12.2 Mediagnost Major Business
2.12.3 Mediagnost IVD ELISA Reagents Product and Solutions
2.12.4 Mediagnost IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Mediagnost Recent Developments and Future Plans
2.13 AESKU.GROUP
2.13.1 AESKU.GROUP Details
2.13.2 AESKU.GROUP Major Business
2.13.3 AESKU.GROUP IVD ELISA Reagents Product and Solutions
2.13.4 AESKU.GROUP IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 AESKU.GROUP Recent Developments and Future Plans
2.14 Monobind
2.14.1 Monobind Details
2.14.2 Monobind Major Business
2.14.3 Monobind IVD ELISA Reagents Product and Solutions
2.14.4 Monobind IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Monobind Recent Developments and Future Plans
2.15 Diagnostics Biochem Canada
2.15.1 Diagnostics Biochem Canada Details
2.15.2 Diagnostics Biochem Canada Major Business
2.15.3 Diagnostics Biochem Canada IVD ELISA Reagents Product and Solutions
2.15.4 Diagnostics Biochem Canada IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Diagnostics Biochem Canada Recent Developments and Future Plans
2.16 Epitope Diagnostics
2.16.1 Epitope Diagnostics Details
2.16.2 Epitope Diagnostics Major Business
2.16.3 Epitope Diagnostics IVD ELISA Reagents Product and Solutions
2.16.4 Epitope Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Epitope Diagnostics Recent Developments and Future Plans
2.17 Beijing Wantai Biological Pharmacy Enterprise
2.17.1 Beijing Wantai Biological Pharmacy Enterprise Details
2.17.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
2.17.3 Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Product and Solutions
2.17.4 Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments and Future Plans
2.18 Shanghai Kehua Bio-engineering
2.18.1 Shanghai Kehua Bio-engineering Details
2.18.2 Shanghai Kehua Bio-engineering Major Business
2.18.3 Shanghai Kehua Bio-engineering IVD ELISA Reagents Product and Solutions
2.18.4 Shanghai Kehua Bio-engineering IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Shanghai Kehua Bio-engineering Recent Developments and Future Plans
2.19 Livzon Pharmaceutical Group
2.19.1 Livzon Pharmaceutical Group Details
2.19.2 Livzon Pharmaceutical Group Major Business
2.19.3 Livzon Pharmaceutical Group IVD ELISA Reagents Product and Solutions
2.19.4 Livzon Pharmaceutical Group IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Livzon Pharmaceutical Group Recent Developments and Future Plans
2.20 Daan Gene
2.20.1 Daan Gene Details
2.20.2 Daan Gene Major Business
2.20.3 Daan Gene IVD ELISA Reagents Product and Solutions
2.20.4 Daan Gene IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Daan Gene Recent Developments and Future Plans
2.21 InTec PRODUCTS
2.21.1 InTec PRODUCTS Details
2.21.2 InTec PRODUCTS Major Business
2.21.3 InTec PRODUCTS IVD ELISA Reagents Product and Solutions
2.21.4 InTec PRODUCTS IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 InTec PRODUCTS Recent Developments and Future Plans
2.22 J. Mitra & Co.
2.22.1 J. Mitra & Co. Details
2.22.2 J. Mitra & Co. Major Business
2.22.3 J. Mitra & Co. IVD ELISA Reagents Product and Solutions
2.22.4 J. Mitra & Co. IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 J. Mitra & Co. Recent Developments and Future Plans
2.23 Meril Life Sciences
2.23.1 Meril Life Sciences Details
2.23.2 Meril Life Sciences Major Business
2.23.3 Meril Life Sciences IVD ELISA Reagents Product and Solutions
2.23.4 Meril Life Sciences IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Meril Life Sciences Recent Developments and Future Plans
2.24 Tulip Diagnostics
2.24.1 Tulip Diagnostics Details
2.24.2 Tulip Diagnostics Major Business
2.24.3 Tulip Diagnostics IVD ELISA Reagents Product and Solutions
2.24.4 Tulip Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Tulip Diagnostics Recent Developments and Future Plans
2.25 Medical & Biological Laboratories
2.25.1 Medical & Biological Laboratories Details
2.25.2 Medical & Biological Laboratories Major Business
2.25.3 Medical & Biological Laboratories IVD ELISA Reagents Product and Solutions
2.25.4 Medical & Biological Laboratories IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Medical & Biological Laboratories Recent Developments and Future Plans
2.26 GenBody
2.26.1 GenBody Details
2.26.2 GenBody Major Business
2.26.3 GenBody IVD ELISA Reagents Product and Solutions
2.26.4 GenBody IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 GenBody Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IVD ELISA Reagents Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of IVD ELISA Reagents by Company Revenue
3.2.2 Top 3 IVD ELISA Reagents Players Market Share in 2025
3.2.3 Top 6 IVD ELISA Reagents Players Market Share in 2025
3.3 IVD ELISA Reagents Market: Overall Company Footprint Analysis
3.3.1 IVD ELISA Reagents Market: Region Footprint
3.3.2 IVD ELISA Reagents Market: Company Product Type Footprint
3.3.3 IVD ELISA Reagents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IVD ELISA Reagents Consumption Value and Market Share by Type (2021-2026)
4.2 Global IVD ELISA Reagents Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IVD ELISA Reagents Consumption Value Market Share by Application (2021-2026)
5.2 Global IVD ELISA Reagents Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America IVD ELISA Reagents Consumption Value by Type (2021-2032)
6.2 North America IVD ELISA Reagents Market Size by Application (2021-2032)
6.3 North America IVD ELISA Reagents Market Size by Country
6.3.1 North America IVD ELISA Reagents Consumption Value by Country (2021-2032)
6.3.2 United States IVD ELISA Reagents Market Size and Forecast (2021-2032)
6.3.3 Canada IVD ELISA Reagents Market Size and Forecast (2021-2032)
6.3.4 Mexico IVD ELISA Reagents Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe IVD ELISA Reagents Consumption Value by Type (2021-2032)
7.2 Europe IVD ELISA Reagents Consumption Value by Application (2021-2032)
7.3 Europe IVD ELISA Reagents Market Size by Country
7.3.1 Europe IVD ELISA Reagents Consumption Value by Country (2021-2032)
7.3.2 Germany IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.3 France IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.4 United Kingdom IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.5 Russia IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.6 Italy IVD ELISA Reagents Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific IVD ELISA Reagents Consumption Value by Type (2021-2032)
8.2 Asia-Pacific IVD ELISA Reagents Consumption Value by Application (2021-2032)
8.3 Asia-Pacific IVD ELISA Reagents Market Size by Region
8.3.1 Asia-Pacific IVD ELISA Reagents Consumption Value by Region (2021-2032)
8.3.2 China IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.3 Japan IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.4 South Korea IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.5 India IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.7 Australia IVD ELISA Reagents Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America IVD ELISA Reagents Consumption Value by Type (2021-2032)
9.2 South America IVD ELISA Reagents Consumption Value by Application (2021-2032)
9.3 South America IVD ELISA Reagents Market Size by Country
9.3.1 South America IVD ELISA Reagents Consumption Value by Country (2021-2032)
9.3.2 Brazil IVD ELISA Reagents Market Size and Forecast (2021-2032)
9.3.3 Argentina IVD ELISA Reagents Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IVD ELISA Reagents Consumption Value by Type (2021-2032)
10.2 Middle East & Africa IVD ELISA Reagents Consumption Value by Application (2021-2032)
10.3 Middle East & Africa IVD ELISA Reagents Market Size by Country
10.3.1 Middle East & Africa IVD ELISA Reagents Consumption Value by Country (2021-2032)
10.3.2 Turkey IVD ELISA Reagents Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia IVD ELISA Reagents Market Size and Forecast (2021-2032)
10.3.4 UAE IVD ELISA Reagents Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 IVD ELISA Reagents Market Drivers
11.2 IVD ELISA Reagents Market Restraints
11.3 IVD ELISA Reagents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IVD ELISA Reagents Industry Chain
12.2 IVD ELISA Reagents Upstream Analysis
12.3 IVD ELISA Reagents Midstream Analysis
12.4 IVD ELISA Reagents Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVD ELISA Reagents by Type
1.3.1 Overview: Global IVD ELISA Reagents Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global IVD ELISA Reagents Consumption Value Market Share by Type in 2025
1.3.3 Antigen Detection
1.3.4 Antibody Detection
1.3.5 Hormone Detection
1.3.6 Other
1.4 Classification of IVD ELISA Reagents by Assay Output
1.4.1 Overview: Global IVD ELISA Reagents Market Size by Assay Output: 2021 Versus 2025 Versus 2032
1.4.2 Global IVD ELISA Reagents Consumption Value Market Share by Assay Output in 2025
1.4.3 Qualitative Assays
1.4.4 Semi-quantitative Assays
1.4.5 Quantitative Assays
1.5 Classification of IVD ELISA Reagents by Assay Format
1.5.1 Overview: Global IVD ELISA Reagents Market Size by Assay Format: 2021 Versus 2025 Versus 2032
1.5.2 Global IVD ELISA Reagents Consumption Value Market Share by Assay Format in 2025
1.5.3 Sandwich ELISA
1.5.4 Indirect ELISA
1.5.5 Other
1.6 Global IVD ELISA Reagents Market by Application
1.6.1 Overview: Global IVD ELISA Reagents Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals and Clinical Laboratories
1.6.3 Blood Centers and Plasma Screening Institutions
1.6.4 Independent Medical Laboratories
1.6.5 Other
1.7 Global IVD ELISA Reagents Market Size & Forecast
1.8 Global IVD ELISA Reagents Market Size and Forecast by Region
1.8.1 Global IVD ELISA Reagents Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global IVD ELISA Reagents Market Size by Region, (2021-2032)
1.8.3 North America IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.4 Europe IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.6 South America IVD ELISA Reagents Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa IVD ELISA Reagents Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Bio-Rad Laboratories
2.1.1 Bio-Rad Laboratories Details
2.1.2 Bio-Rad Laboratories Major Business
2.1.3 Bio-Rad Laboratories IVD ELISA Reagents Product and Solutions
2.1.4 Bio-Rad Laboratories IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.2 Revvity
2.2.1 Revvity Details
2.2.2 Revvity Major Business
2.2.3 Revvity IVD ELISA Reagents Product and Solutions
2.2.4 Revvity IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Revvity Recent Developments and Future Plans
2.3 Sebia
2.3.1 Sebia Details
2.3.2 Sebia Major Business
2.3.3 Sebia IVD ELISA Reagents Product and Solutions
2.3.4 Sebia IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sebia Recent Developments and Future Plans
2.4 Tecan Group
2.4.1 Tecan Group Details
2.4.2 Tecan Group Major Business
2.4.3 Tecan Group IVD ELISA Reagents Product and Solutions
2.4.4 Tecan Group IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Tecan Group Recent Developments and Future Plans
2.5 BioVendor Group
2.5.1 BioVendor Group Details
2.5.2 BioVendor Group Major Business
2.5.3 BioVendor Group IVD ELISA Reagents Product and Solutions
2.5.4 BioVendor Group IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 BioVendor Group Recent Developments and Future Plans
2.6 Trinity Biotech
2.6.1 Trinity Biotech Details
2.6.2 Trinity Biotech Major Business
2.6.3 Trinity Biotech IVD ELISA Reagents Product and Solutions
2.6.4 Trinity Biotech IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Trinity Biotech Recent Developments and Future Plans
2.7 Dia.Pro Diagnostic Bioprobes
2.7.1 Dia.Pro Diagnostic Bioprobes Details
2.7.2 Dia.Pro Diagnostic Bioprobes Major Business
2.7.3 Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Product and Solutions
2.7.4 Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Dia.Pro Diagnostic Bioprobes Recent Developments and Future Plans
2.8 Vircell
2.8.1 Vircell Details
2.8.2 Vircell Major Business
2.8.3 Vircell IVD ELISA Reagents Product and Solutions
2.8.4 Vircell IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Vircell Recent Developments and Future Plans
2.9 SERION Diagnostics
2.9.1 SERION Diagnostics Details
2.9.2 SERION Diagnostics Major Business
2.9.3 SERION Diagnostics IVD ELISA Reagents Product and Solutions
2.9.4 SERION Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 SERION Diagnostics Recent Developments and Future Plans
2.10 DRG International
2.10.1 DRG International Details
2.10.2 DRG International Major Business
2.10.3 DRG International IVD ELISA Reagents Product and Solutions
2.10.4 DRG International IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 DRG International Recent Developments and Future Plans
2.11 Demeditec Diagnostics
2.11.1 Demeditec Diagnostics Details
2.11.2 Demeditec Diagnostics Major Business
2.11.3 Demeditec Diagnostics IVD ELISA Reagents Product and Solutions
2.11.4 Demeditec Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Demeditec Diagnostics Recent Developments and Future Plans
2.12 Mediagnost
2.12.1 Mediagnost Details
2.12.2 Mediagnost Major Business
2.12.3 Mediagnost IVD ELISA Reagents Product and Solutions
2.12.4 Mediagnost IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Mediagnost Recent Developments and Future Plans
2.13 AESKU.GROUP
2.13.1 AESKU.GROUP Details
2.13.2 AESKU.GROUP Major Business
2.13.3 AESKU.GROUP IVD ELISA Reagents Product and Solutions
2.13.4 AESKU.GROUP IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 AESKU.GROUP Recent Developments and Future Plans
2.14 Monobind
2.14.1 Monobind Details
2.14.2 Monobind Major Business
2.14.3 Monobind IVD ELISA Reagents Product and Solutions
2.14.4 Monobind IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Monobind Recent Developments and Future Plans
2.15 Diagnostics Biochem Canada
2.15.1 Diagnostics Biochem Canada Details
2.15.2 Diagnostics Biochem Canada Major Business
2.15.3 Diagnostics Biochem Canada IVD ELISA Reagents Product and Solutions
2.15.4 Diagnostics Biochem Canada IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Diagnostics Biochem Canada Recent Developments and Future Plans
2.16 Epitope Diagnostics
2.16.1 Epitope Diagnostics Details
2.16.2 Epitope Diagnostics Major Business
2.16.3 Epitope Diagnostics IVD ELISA Reagents Product and Solutions
2.16.4 Epitope Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Epitope Diagnostics Recent Developments and Future Plans
2.17 Beijing Wantai Biological Pharmacy Enterprise
2.17.1 Beijing Wantai Biological Pharmacy Enterprise Details
2.17.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
2.17.3 Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Product and Solutions
2.17.4 Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments and Future Plans
2.18 Shanghai Kehua Bio-engineering
2.18.1 Shanghai Kehua Bio-engineering Details
2.18.2 Shanghai Kehua Bio-engineering Major Business
2.18.3 Shanghai Kehua Bio-engineering IVD ELISA Reagents Product and Solutions
2.18.4 Shanghai Kehua Bio-engineering IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Shanghai Kehua Bio-engineering Recent Developments and Future Plans
2.19 Livzon Pharmaceutical Group
2.19.1 Livzon Pharmaceutical Group Details
2.19.2 Livzon Pharmaceutical Group Major Business
2.19.3 Livzon Pharmaceutical Group IVD ELISA Reagents Product and Solutions
2.19.4 Livzon Pharmaceutical Group IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Livzon Pharmaceutical Group Recent Developments and Future Plans
2.20 Daan Gene
2.20.1 Daan Gene Details
2.20.2 Daan Gene Major Business
2.20.3 Daan Gene IVD ELISA Reagents Product and Solutions
2.20.4 Daan Gene IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Daan Gene Recent Developments and Future Plans
2.21 InTec PRODUCTS
2.21.1 InTec PRODUCTS Details
2.21.2 InTec PRODUCTS Major Business
2.21.3 InTec PRODUCTS IVD ELISA Reagents Product and Solutions
2.21.4 InTec PRODUCTS IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 InTec PRODUCTS Recent Developments and Future Plans
2.22 J. Mitra & Co.
2.22.1 J. Mitra & Co. Details
2.22.2 J. Mitra & Co. Major Business
2.22.3 J. Mitra & Co. IVD ELISA Reagents Product and Solutions
2.22.4 J. Mitra & Co. IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 J. Mitra & Co. Recent Developments and Future Plans
2.23 Meril Life Sciences
2.23.1 Meril Life Sciences Details
2.23.2 Meril Life Sciences Major Business
2.23.3 Meril Life Sciences IVD ELISA Reagents Product and Solutions
2.23.4 Meril Life Sciences IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Meril Life Sciences Recent Developments and Future Plans
2.24 Tulip Diagnostics
2.24.1 Tulip Diagnostics Details
2.24.2 Tulip Diagnostics Major Business
2.24.3 Tulip Diagnostics IVD ELISA Reagents Product and Solutions
2.24.4 Tulip Diagnostics IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Tulip Diagnostics Recent Developments and Future Plans
2.25 Medical & Biological Laboratories
2.25.1 Medical & Biological Laboratories Details
2.25.2 Medical & Biological Laboratories Major Business
2.25.3 Medical & Biological Laboratories IVD ELISA Reagents Product and Solutions
2.25.4 Medical & Biological Laboratories IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Medical & Biological Laboratories Recent Developments and Future Plans
2.26 GenBody
2.26.1 GenBody Details
2.26.2 GenBody Major Business
2.26.3 GenBody IVD ELISA Reagents Product and Solutions
2.26.4 GenBody IVD ELISA Reagents Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 GenBody Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IVD ELISA Reagents Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of IVD ELISA Reagents by Company Revenue
3.2.2 Top 3 IVD ELISA Reagents Players Market Share in 2025
3.2.3 Top 6 IVD ELISA Reagents Players Market Share in 2025
3.3 IVD ELISA Reagents Market: Overall Company Footprint Analysis
3.3.1 IVD ELISA Reagents Market: Region Footprint
3.3.2 IVD ELISA Reagents Market: Company Product Type Footprint
3.3.3 IVD ELISA Reagents Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IVD ELISA Reagents Consumption Value and Market Share by Type (2021-2026)
4.2 Global IVD ELISA Reagents Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IVD ELISA Reagents Consumption Value Market Share by Application (2021-2026)
5.2 Global IVD ELISA Reagents Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America IVD ELISA Reagents Consumption Value by Type (2021-2032)
6.2 North America IVD ELISA Reagents Market Size by Application (2021-2032)
6.3 North America IVD ELISA Reagents Market Size by Country
6.3.1 North America IVD ELISA Reagents Consumption Value by Country (2021-2032)
6.3.2 United States IVD ELISA Reagents Market Size and Forecast (2021-2032)
6.3.3 Canada IVD ELISA Reagents Market Size and Forecast (2021-2032)
6.3.4 Mexico IVD ELISA Reagents Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe IVD ELISA Reagents Consumption Value by Type (2021-2032)
7.2 Europe IVD ELISA Reagents Consumption Value by Application (2021-2032)
7.3 Europe IVD ELISA Reagents Market Size by Country
7.3.1 Europe IVD ELISA Reagents Consumption Value by Country (2021-2032)
7.3.2 Germany IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.3 France IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.4 United Kingdom IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.5 Russia IVD ELISA Reagents Market Size and Forecast (2021-2032)
7.3.6 Italy IVD ELISA Reagents Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific IVD ELISA Reagents Consumption Value by Type (2021-2032)
8.2 Asia-Pacific IVD ELISA Reagents Consumption Value by Application (2021-2032)
8.3 Asia-Pacific IVD ELISA Reagents Market Size by Region
8.3.1 Asia-Pacific IVD ELISA Reagents Consumption Value by Region (2021-2032)
8.3.2 China IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.3 Japan IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.4 South Korea IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.5 India IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia IVD ELISA Reagents Market Size and Forecast (2021-2032)
8.3.7 Australia IVD ELISA Reagents Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America IVD ELISA Reagents Consumption Value by Type (2021-2032)
9.2 South America IVD ELISA Reagents Consumption Value by Application (2021-2032)
9.3 South America IVD ELISA Reagents Market Size by Country
9.3.1 South America IVD ELISA Reagents Consumption Value by Country (2021-2032)
9.3.2 Brazil IVD ELISA Reagents Market Size and Forecast (2021-2032)
9.3.3 Argentina IVD ELISA Reagents Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IVD ELISA Reagents Consumption Value by Type (2021-2032)
10.2 Middle East & Africa IVD ELISA Reagents Consumption Value by Application (2021-2032)
10.3 Middle East & Africa IVD ELISA Reagents Market Size by Country
10.3.1 Middle East & Africa IVD ELISA Reagents Consumption Value by Country (2021-2032)
10.3.2 Turkey IVD ELISA Reagents Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia IVD ELISA Reagents Market Size and Forecast (2021-2032)
10.3.4 UAE IVD ELISA Reagents Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 IVD ELISA Reagents Market Drivers
11.2 IVD ELISA Reagents Market Restraints
11.3 IVD ELISA Reagents Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IVD ELISA Reagents Industry Chain
12.2 IVD ELISA Reagents Upstream Analysis
12.3 IVD ELISA Reagents Midstream Analysis
12.4 IVD ELISA Reagents Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global IVD ELISA Reagents Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global IVD ELISA Reagents Consumption Value by Assay Output, (USD Million), 2021 & 2025 & 2032
Table 3. Global IVD ELISA Reagents Consumption Value by Assay Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global IVD ELISA Reagents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global IVD ELISA Reagents Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global IVD ELISA Reagents Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 8. Bio-Rad Laboratories Major Business
Table 9. Bio-Rad Laboratories IVD ELISA Reagents Product and Solutions
Table 10. Bio-Rad Laboratories IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Bio-Rad Laboratories Recent Developments and Future Plans
Table 12. Revvity Company Information, Head Office, and Major Competitors
Table 13. Revvity Major Business
Table 14. Revvity IVD ELISA Reagents Product and Solutions
Table 15. Revvity IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Revvity Recent Developments and Future Plans
Table 17. Sebia Company Information, Head Office, and Major Competitors
Table 18. Sebia Major Business
Table 19. Sebia IVD ELISA Reagents Product and Solutions
Table 20. Sebia IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Tecan Group Company Information, Head Office, and Major Competitors
Table 22. Tecan Group Major Business
Table 23. Tecan Group IVD ELISA Reagents Product and Solutions
Table 24. Tecan Group IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Tecan Group Recent Developments and Future Plans
Table 26. BioVendor Group Company Information, Head Office, and Major Competitors
Table 27. BioVendor Group Major Business
Table 28. BioVendor Group IVD ELISA Reagents Product and Solutions
Table 29. BioVendor Group IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. BioVendor Group Recent Developments and Future Plans
Table 31. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 32. Trinity Biotech Major Business
Table 33. Trinity Biotech IVD ELISA Reagents Product and Solutions
Table 34. Trinity Biotech IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Trinity Biotech Recent Developments and Future Plans
Table 36. Dia.Pro Diagnostic Bioprobes Company Information, Head Office, and Major Competitors
Table 37. Dia.Pro Diagnostic Bioprobes Major Business
Table 38. Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Product and Solutions
Table 39. Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Dia.Pro Diagnostic Bioprobes Recent Developments and Future Plans
Table 41. Vircell Company Information, Head Office, and Major Competitors
Table 42. Vircell Major Business
Table 43. Vircell IVD ELISA Reagents Product and Solutions
Table 44. Vircell IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Vircell Recent Developments and Future Plans
Table 46. SERION Diagnostics Company Information, Head Office, and Major Competitors
Table 47. SERION Diagnostics Major Business
Table 48. SERION Diagnostics IVD ELISA Reagents Product and Solutions
Table 49. SERION Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. SERION Diagnostics Recent Developments and Future Plans
Table 51. DRG International Company Information, Head Office, and Major Competitors
Table 52. DRG International Major Business
Table 53. DRG International IVD ELISA Reagents Product and Solutions
Table 54. DRG International IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. DRG International Recent Developments and Future Plans
Table 56. Demeditec Diagnostics Company Information, Head Office, and Major Competitors
Table 57. Demeditec Diagnostics Major Business
Table 58. Demeditec Diagnostics IVD ELISA Reagents Product and Solutions
Table 59. Demeditec Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Demeditec Diagnostics Recent Developments and Future Plans
Table 61. Mediagnost Company Information, Head Office, and Major Competitors
Table 62. Mediagnost Major Business
Table 63. Mediagnost IVD ELISA Reagents Product and Solutions
Table 64. Mediagnost IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Mediagnost Recent Developments and Future Plans
Table 66. AESKU.GROUP Company Information, Head Office, and Major Competitors
Table 67. AESKU.GROUP Major Business
Table 68. AESKU.GROUP IVD ELISA Reagents Product and Solutions
Table 69. AESKU.GROUP IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. AESKU.GROUP Recent Developments and Future Plans
Table 71. Monobind Company Information, Head Office, and Major Competitors
Table 72. Monobind Major Business
Table 73. Monobind IVD ELISA Reagents Product and Solutions
Table 74. Monobind IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Monobind Recent Developments and Future Plans
Table 76. Diagnostics Biochem Canada Company Information, Head Office, and Major Competitors
Table 77. Diagnostics Biochem Canada Major Business
Table 78. Diagnostics Biochem Canada IVD ELISA Reagents Product and Solutions
Table 79. Diagnostics Biochem Canada IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Diagnostics Biochem Canada Recent Developments and Future Plans
Table 81. Epitope Diagnostics Company Information, Head Office, and Major Competitors
Table 82. Epitope Diagnostics Major Business
Table 83. Epitope Diagnostics IVD ELISA Reagents Product and Solutions
Table 84. Epitope Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Epitope Diagnostics Recent Developments and Future Plans
Table 86. Beijing Wantai Biological Pharmacy Enterprise Company Information, Head Office, and Major Competitors
Table 87. Beijing Wantai Biological Pharmacy Enterprise Major Business
Table 88. Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Product and Solutions
Table 89. Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Beijing Wantai Biological Pharmacy Enterprise Recent Developments and Future Plans
Table 91. Shanghai Kehua Bio-engineering Company Information, Head Office, and Major Competitors
Table 92. Shanghai Kehua Bio-engineering Major Business
Table 93. Shanghai Kehua Bio-engineering IVD ELISA Reagents Product and Solutions
Table 94. Shanghai Kehua Bio-engineering IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Shanghai Kehua Bio-engineering Recent Developments and Future Plans
Table 96. Livzon Pharmaceutical Group Company Information, Head Office, and Major Competitors
Table 97. Livzon Pharmaceutical Group Major Business
Table 98. Livzon Pharmaceutical Group IVD ELISA Reagents Product and Solutions
Table 99. Livzon Pharmaceutical Group IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Livzon Pharmaceutical Group Recent Developments and Future Plans
Table 101. Daan Gene Company Information, Head Office, and Major Competitors
Table 102. Daan Gene Major Business
Table 103. Daan Gene IVD ELISA Reagents Product and Solutions
Table 104. Daan Gene IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Daan Gene Recent Developments and Future Plans
Table 106. InTec PRODUCTS Company Information, Head Office, and Major Competitors
Table 107. InTec PRODUCTS Major Business
Table 108. InTec PRODUCTS IVD ELISA Reagents Product and Solutions
Table 109. InTec PRODUCTS IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. InTec PRODUCTS Recent Developments and Future Plans
Table 111. J. Mitra & Co. Company Information, Head Office, and Major Competitors
Table 112. J. Mitra & Co. Major Business
Table 113. J. Mitra & Co. IVD ELISA Reagents Product and Solutions
Table 114. J. Mitra & Co. IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. J. Mitra & Co. Recent Developments and Future Plans
Table 116. Meril Life Sciences Company Information, Head Office, and Major Competitors
Table 117. Meril Life Sciences Major Business
Table 118. Meril Life Sciences IVD ELISA Reagents Product and Solutions
Table 119. Meril Life Sciences IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Meril Life Sciences Recent Developments and Future Plans
Table 121. Tulip Diagnostics Company Information, Head Office, and Major Competitors
Table 122. Tulip Diagnostics Major Business
Table 123. Tulip Diagnostics IVD ELISA Reagents Product and Solutions
Table 124. Tulip Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Tulip Diagnostics Recent Developments and Future Plans
Table 126. Medical & Biological Laboratories Company Information, Head Office, and Major Competitors
Table 127. Medical & Biological Laboratories Major Business
Table 128. Medical & Biological Laboratories IVD ELISA Reagents Product and Solutions
Table 129. Medical & Biological Laboratories IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Medical & Biological Laboratories Recent Developments and Future Plans
Table 131. GenBody Company Information, Head Office, and Major Competitors
Table 132. GenBody Major Business
Table 133. GenBody IVD ELISA Reagents Product and Solutions
Table 134. GenBody IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. GenBody Recent Developments and Future Plans
Table 136. Global IVD ELISA Reagents Revenue (USD Million) by Players (2021-2026)
Table 137. Global IVD ELISA Reagents Revenue Share by Players (2021-2026)
Table 138. Breakdown of IVD ELISA Reagents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 139. Market Position of Players in IVD ELISA Reagents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 140. Head Office of Key IVD ELISA Reagents Players
Table 141. IVD ELISA Reagents Market: Company Product Type Footprint
Table 142. IVD ELISA Reagents Market: Company Product Application Footprint
Table 143. IVD ELISA Reagents New Market Entrants and Barriers to Market Entry
Table 144. IVD ELISA Reagents Mergers, Acquisition, Agreements, and Collaborations
Table 145. Global IVD ELISA Reagents Consumption Value (USD Million) by Type (2021-2026)
Table 146. Global IVD ELISA Reagents Consumption Value Share by Type (2021-2026)
Table 147. Global IVD ELISA Reagents Consumption Value Forecast by Type (2027-2032)
Table 148. Global IVD ELISA Reagents Consumption Value by Application (2021-2026)
Table 149. Global IVD ELISA Reagents Consumption Value Forecast by Application (2027-2032)
Table 150. North America IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 151. North America IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 152. North America IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 153. North America IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 154. North America IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 155. North America IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Europe IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 157. Europe IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 158. Europe IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 159. Europe IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 160. Europe IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 161. Europe IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Asia-Pacific IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 163. Asia-Pacific IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 164. Asia-Pacific IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 165. Asia-Pacific IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 166. Asia-Pacific IVD ELISA Reagents Consumption Value by Region (2021-2026) & (USD Million)
Table 167. Asia-Pacific IVD ELISA Reagents Consumption Value by Region (2027-2032) & (USD Million)
Table 168. South America IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 169. South America IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 170. South America IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 171. South America IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 172. South America IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 173. South America IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 174. Middle East & Africa IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 175. Middle East & Africa IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 176. Middle East & Africa IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 177. Middle East & Africa IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 178. Middle East & Africa IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 179. Middle East & Africa IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 180. Global Key Players of IVD ELISA Reagents Upstream (Raw Materials)
Table 181. Global IVD ELISA Reagents Typical Customers
Table 1. Global IVD ELISA Reagents Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global IVD ELISA Reagents Consumption Value by Assay Output, (USD Million), 2021 & 2025 & 2032
Table 3. Global IVD ELISA Reagents Consumption Value by Assay Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global IVD ELISA Reagents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global IVD ELISA Reagents Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global IVD ELISA Reagents Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 8. Bio-Rad Laboratories Major Business
Table 9. Bio-Rad Laboratories IVD ELISA Reagents Product and Solutions
Table 10. Bio-Rad Laboratories IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Bio-Rad Laboratories Recent Developments and Future Plans
Table 12. Revvity Company Information, Head Office, and Major Competitors
Table 13. Revvity Major Business
Table 14. Revvity IVD ELISA Reagents Product and Solutions
Table 15. Revvity IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Revvity Recent Developments and Future Plans
Table 17. Sebia Company Information, Head Office, and Major Competitors
Table 18. Sebia Major Business
Table 19. Sebia IVD ELISA Reagents Product and Solutions
Table 20. Sebia IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Tecan Group Company Information, Head Office, and Major Competitors
Table 22. Tecan Group Major Business
Table 23. Tecan Group IVD ELISA Reagents Product and Solutions
Table 24. Tecan Group IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Tecan Group Recent Developments and Future Plans
Table 26. BioVendor Group Company Information, Head Office, and Major Competitors
Table 27. BioVendor Group Major Business
Table 28. BioVendor Group IVD ELISA Reagents Product and Solutions
Table 29. BioVendor Group IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. BioVendor Group Recent Developments and Future Plans
Table 31. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 32. Trinity Biotech Major Business
Table 33. Trinity Biotech IVD ELISA Reagents Product and Solutions
Table 34. Trinity Biotech IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Trinity Biotech Recent Developments and Future Plans
Table 36. Dia.Pro Diagnostic Bioprobes Company Information, Head Office, and Major Competitors
Table 37. Dia.Pro Diagnostic Bioprobes Major Business
Table 38. Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Product and Solutions
Table 39. Dia.Pro Diagnostic Bioprobes IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Dia.Pro Diagnostic Bioprobes Recent Developments and Future Plans
Table 41. Vircell Company Information, Head Office, and Major Competitors
Table 42. Vircell Major Business
Table 43. Vircell IVD ELISA Reagents Product and Solutions
Table 44. Vircell IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Vircell Recent Developments and Future Plans
Table 46. SERION Diagnostics Company Information, Head Office, and Major Competitors
Table 47. SERION Diagnostics Major Business
Table 48. SERION Diagnostics IVD ELISA Reagents Product and Solutions
Table 49. SERION Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. SERION Diagnostics Recent Developments and Future Plans
Table 51. DRG International Company Information, Head Office, and Major Competitors
Table 52. DRG International Major Business
Table 53. DRG International IVD ELISA Reagents Product and Solutions
Table 54. DRG International IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. DRG International Recent Developments and Future Plans
Table 56. Demeditec Diagnostics Company Information, Head Office, and Major Competitors
Table 57. Demeditec Diagnostics Major Business
Table 58. Demeditec Diagnostics IVD ELISA Reagents Product and Solutions
Table 59. Demeditec Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Demeditec Diagnostics Recent Developments and Future Plans
Table 61. Mediagnost Company Information, Head Office, and Major Competitors
Table 62. Mediagnost Major Business
Table 63. Mediagnost IVD ELISA Reagents Product and Solutions
Table 64. Mediagnost IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Mediagnost Recent Developments and Future Plans
Table 66. AESKU.GROUP Company Information, Head Office, and Major Competitors
Table 67. AESKU.GROUP Major Business
Table 68. AESKU.GROUP IVD ELISA Reagents Product and Solutions
Table 69. AESKU.GROUP IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. AESKU.GROUP Recent Developments and Future Plans
Table 71. Monobind Company Information, Head Office, and Major Competitors
Table 72. Monobind Major Business
Table 73. Monobind IVD ELISA Reagents Product and Solutions
Table 74. Monobind IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Monobind Recent Developments and Future Plans
Table 76. Diagnostics Biochem Canada Company Information, Head Office, and Major Competitors
Table 77. Diagnostics Biochem Canada Major Business
Table 78. Diagnostics Biochem Canada IVD ELISA Reagents Product and Solutions
Table 79. Diagnostics Biochem Canada IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Diagnostics Biochem Canada Recent Developments and Future Plans
Table 81. Epitope Diagnostics Company Information, Head Office, and Major Competitors
Table 82. Epitope Diagnostics Major Business
Table 83. Epitope Diagnostics IVD ELISA Reagents Product and Solutions
Table 84. Epitope Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Epitope Diagnostics Recent Developments and Future Plans
Table 86. Beijing Wantai Biological Pharmacy Enterprise Company Information, Head Office, and Major Competitors
Table 87. Beijing Wantai Biological Pharmacy Enterprise Major Business
Table 88. Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Product and Solutions
Table 89. Beijing Wantai Biological Pharmacy Enterprise IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Beijing Wantai Biological Pharmacy Enterprise Recent Developments and Future Plans
Table 91. Shanghai Kehua Bio-engineering Company Information, Head Office, and Major Competitors
Table 92. Shanghai Kehua Bio-engineering Major Business
Table 93. Shanghai Kehua Bio-engineering IVD ELISA Reagents Product and Solutions
Table 94. Shanghai Kehua Bio-engineering IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Shanghai Kehua Bio-engineering Recent Developments and Future Plans
Table 96. Livzon Pharmaceutical Group Company Information, Head Office, and Major Competitors
Table 97. Livzon Pharmaceutical Group Major Business
Table 98. Livzon Pharmaceutical Group IVD ELISA Reagents Product and Solutions
Table 99. Livzon Pharmaceutical Group IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Livzon Pharmaceutical Group Recent Developments and Future Plans
Table 101. Daan Gene Company Information, Head Office, and Major Competitors
Table 102. Daan Gene Major Business
Table 103. Daan Gene IVD ELISA Reagents Product and Solutions
Table 104. Daan Gene IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Daan Gene Recent Developments and Future Plans
Table 106. InTec PRODUCTS Company Information, Head Office, and Major Competitors
Table 107. InTec PRODUCTS Major Business
Table 108. InTec PRODUCTS IVD ELISA Reagents Product and Solutions
Table 109. InTec PRODUCTS IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. InTec PRODUCTS Recent Developments and Future Plans
Table 111. J. Mitra & Co. Company Information, Head Office, and Major Competitors
Table 112. J. Mitra & Co. Major Business
Table 113. J. Mitra & Co. IVD ELISA Reagents Product and Solutions
Table 114. J. Mitra & Co. IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. J. Mitra & Co. Recent Developments and Future Plans
Table 116. Meril Life Sciences Company Information, Head Office, and Major Competitors
Table 117. Meril Life Sciences Major Business
Table 118. Meril Life Sciences IVD ELISA Reagents Product and Solutions
Table 119. Meril Life Sciences IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Meril Life Sciences Recent Developments and Future Plans
Table 121. Tulip Diagnostics Company Information, Head Office, and Major Competitors
Table 122. Tulip Diagnostics Major Business
Table 123. Tulip Diagnostics IVD ELISA Reagents Product and Solutions
Table 124. Tulip Diagnostics IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Tulip Diagnostics Recent Developments and Future Plans
Table 126. Medical & Biological Laboratories Company Information, Head Office, and Major Competitors
Table 127. Medical & Biological Laboratories Major Business
Table 128. Medical & Biological Laboratories IVD ELISA Reagents Product and Solutions
Table 129. Medical & Biological Laboratories IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Medical & Biological Laboratories Recent Developments and Future Plans
Table 131. GenBody Company Information, Head Office, and Major Competitors
Table 132. GenBody Major Business
Table 133. GenBody IVD ELISA Reagents Product and Solutions
Table 134. GenBody IVD ELISA Reagents Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. GenBody Recent Developments and Future Plans
Table 136. Global IVD ELISA Reagents Revenue (USD Million) by Players (2021-2026)
Table 137. Global IVD ELISA Reagents Revenue Share by Players (2021-2026)
Table 138. Breakdown of IVD ELISA Reagents by Company Type (Tier 1, Tier 2, and Tier 3)
Table 139. Market Position of Players in IVD ELISA Reagents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 140. Head Office of Key IVD ELISA Reagents Players
Table 141. IVD ELISA Reagents Market: Company Product Type Footprint
Table 142. IVD ELISA Reagents Market: Company Product Application Footprint
Table 143. IVD ELISA Reagents New Market Entrants and Barriers to Market Entry
Table 144. IVD ELISA Reagents Mergers, Acquisition, Agreements, and Collaborations
Table 145. Global IVD ELISA Reagents Consumption Value (USD Million) by Type (2021-2026)
Table 146. Global IVD ELISA Reagents Consumption Value Share by Type (2021-2026)
Table 147. Global IVD ELISA Reagents Consumption Value Forecast by Type (2027-2032)
Table 148. Global IVD ELISA Reagents Consumption Value by Application (2021-2026)
Table 149. Global IVD ELISA Reagents Consumption Value Forecast by Application (2027-2032)
Table 150. North America IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 151. North America IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 152. North America IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 153. North America IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 154. North America IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 155. North America IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Europe IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 157. Europe IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 158. Europe IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 159. Europe IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 160. Europe IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 161. Europe IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Asia-Pacific IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 163. Asia-Pacific IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 164. Asia-Pacific IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 165. Asia-Pacific IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 166. Asia-Pacific IVD ELISA Reagents Consumption Value by Region (2021-2026) & (USD Million)
Table 167. Asia-Pacific IVD ELISA Reagents Consumption Value by Region (2027-2032) & (USD Million)
Table 168. South America IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 169. South America IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 170. South America IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 171. South America IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 172. South America IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 173. South America IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 174. Middle East & Africa IVD ELISA Reagents Consumption Value by Type (2021-2026) & (USD Million)
Table 175. Middle East & Africa IVD ELISA Reagents Consumption Value by Type (2027-2032) & (USD Million)
Table 176. Middle East & Africa IVD ELISA Reagents Consumption Value by Application (2021-2026) & (USD Million)
Table 177. Middle East & Africa IVD ELISA Reagents Consumption Value by Application (2027-2032) & (USD Million)
Table 178. Middle East & Africa IVD ELISA Reagents Consumption Value by Country (2021-2026) & (USD Million)
Table 179. Middle East & Africa IVD ELISA Reagents Consumption Value by Country (2027-2032) & (USD Million)
Table 180. Global Key Players of IVD ELISA Reagents Upstream (Raw Materials)
Table 181. Global IVD ELISA Reagents Typical Customers
LIST OF FIGURES
Figure 1. IVD ELISA Reagents Picture
Figure 2. Global IVD ELISA Reagents Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global IVD ELISA Reagents Consumption Value Market Share by Type in 2025
Figure 4. Antigen Detection
Figure 5. Antibody Detection
Figure 6. Hormone Detection
Figure 7. Other
Figure 8. Global IVD ELISA Reagents Consumption Value by Assay Output, (USD Million), 2021 & 2025 & 2032
Figure 9. Global IVD ELISA Reagents Consumption Value Market Share by Assay Output in 2025
Figure 10. Qualitative Assays
Figure 11. Semi-quantitative Assays
Figure 12. Quantitative Assays
Figure 13. Global IVD ELISA Reagents Consumption Value by Assay Format, (USD Million), 2021 & 2025 & 2032
Figure 14. Global IVD ELISA Reagents Consumption Value Market Share by Assay Format in 2025
Figure 15. Sandwich ELISA
Figure 16. Indirect ELISA
Figure 17. Other
Figure 18. Global IVD ELISA Reagents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. IVD ELISA Reagents Consumption Value Market Share by Application in 2025
Figure 20. Hospitals and Clinical Laboratories Picture
Figure 21. Blood Centers and Plasma Screening Institutions Picture
Figure 22. Independent Medical Laboratories Picture
Figure 23. Other Picture
Figure 24. Global IVD ELISA Reagents Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global IVD ELISA Reagents Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market IVD ELISA Reagents Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global IVD ELISA Reagents Consumption Value Market Share by Region (2021-2032)
Figure 28. Global IVD ELISA Reagents Consumption Value Market Share by Region in 2025
Figure 29. North America IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 32. South America IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global IVD ELISA Reagents Revenue Share by Players in 2025
Figure 36. IVD ELISA Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of IVD ELISA Reagents by Player Revenue in 2025
Figure 38. Top 3 IVD ELISA Reagents Players Market Share in 2025
Figure 39. Top 6 IVD ELISA Reagents Players Market Share in 2025
Figure 40. Global IVD ELISA Reagents Consumption Value Share by Type (2021-2026)
Figure 41. Global IVD ELISA Reagents Market Share Forecast by Type (2027-2032)
Figure 42. Global IVD ELISA Reagents Consumption Value Share by Application (2021-2026)
Figure 43. Global IVD ELISA Reagents Market Share Forecast by Application (2027-2032)
Figure 44. North America IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 45. North America IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 46. North America IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 47. United States IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 54. France IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific IVD ELISA Reagents Consumption Value Market Share by Region (2021-2032)
Figure 61. China IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 64. India IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 67. South America IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 68. South America IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 69. South America IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 78. IVD ELISA Reagents Market Drivers
Figure 79. IVD ELISA Reagents Market Restraints
Figure 80. IVD ELISA Reagents Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. IVD ELISA Reagents Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. IVD ELISA Reagents Picture
Figure 2. Global IVD ELISA Reagents Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global IVD ELISA Reagents Consumption Value Market Share by Type in 2025
Figure 4. Antigen Detection
Figure 5. Antibody Detection
Figure 6. Hormone Detection
Figure 7. Other
Figure 8. Global IVD ELISA Reagents Consumption Value by Assay Output, (USD Million), 2021 & 2025 & 2032
Figure 9. Global IVD ELISA Reagents Consumption Value Market Share by Assay Output in 2025
Figure 10. Qualitative Assays
Figure 11. Semi-quantitative Assays
Figure 12. Quantitative Assays
Figure 13. Global IVD ELISA Reagents Consumption Value by Assay Format, (USD Million), 2021 & 2025 & 2032
Figure 14. Global IVD ELISA Reagents Consumption Value Market Share by Assay Format in 2025
Figure 15. Sandwich ELISA
Figure 16. Indirect ELISA
Figure 17. Other
Figure 18. Global IVD ELISA Reagents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. IVD ELISA Reagents Consumption Value Market Share by Application in 2025
Figure 20. Hospitals and Clinical Laboratories Picture
Figure 21. Blood Centers and Plasma Screening Institutions Picture
Figure 22. Independent Medical Laboratories Picture
Figure 23. Other Picture
Figure 24. Global IVD ELISA Reagents Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global IVD ELISA Reagents Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market IVD ELISA Reagents Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global IVD ELISA Reagents Consumption Value Market Share by Region (2021-2032)
Figure 28. Global IVD ELISA Reagents Consumption Value Market Share by Region in 2025
Figure 29. North America IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 32. South America IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global IVD ELISA Reagents Revenue Share by Players in 2025
Figure 36. IVD ELISA Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of IVD ELISA Reagents by Player Revenue in 2025
Figure 38. Top 3 IVD ELISA Reagents Players Market Share in 2025
Figure 39. Top 6 IVD ELISA Reagents Players Market Share in 2025
Figure 40. Global IVD ELISA Reagents Consumption Value Share by Type (2021-2026)
Figure 41. Global IVD ELISA Reagents Market Share Forecast by Type (2027-2032)
Figure 42. Global IVD ELISA Reagents Consumption Value Share by Application (2021-2026)
Figure 43. Global IVD ELISA Reagents Market Share Forecast by Application (2027-2032)
Figure 44. North America IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 45. North America IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 46. North America IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 47. United States IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 54. France IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific IVD ELISA Reagents Consumption Value Market Share by Region (2021-2032)
Figure 61. China IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 64. India IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 67. South America IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 68. South America IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 69. South America IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa IVD ELISA Reagents Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa IVD ELISA Reagents Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa IVD ELISA Reagents Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE IVD ELISA Reagents Consumption Value (2021-2032) & (USD Million)
Figure 78. IVD ELISA Reagents Market Drivers
Figure 79. IVD ELISA Reagents Market Restraints
Figure 80. IVD ELISA Reagents Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. IVD ELISA Reagents Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
